Amgen Inc. (AMGN): Price and Financial Metrics


Amgen Inc. (AMGN): $213.61

-1.44 (-0.67%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AMGN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 505

in industry

AMGN POWR Grades


  • AMGN scores best on the Quality dimension, with a Quality rank ahead of 97.98% of US stocks.
  • AMGN's strongest trending metric is Momentum; it's been moving down over the last 48 weeks.
  • AMGN's current lowest rank is in the Momentum metric (where it is better than 13.9% of US stocks).

AMGN Stock Summary

  • With a market capitalization of $122,116,648,513, Amgen Inc has a greater market value than 97.83% of US stocks.
  • AMGN's went public 35.75 years ago, making it older than 92.65% of listed US stocks we're tracking.
  • In terms of volatility of its share price, AMGN is more volatile than only 4.36% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Amgen Inc, a group of peers worth examining would be RTX, GSK, DE, GILD, and BMY.
  • AMGN's SEC filings can be seen here. And to visit Amgen Inc's official web site, go to www.amgen.com.

AMGN Valuation Summary

  • In comparison to the median Healthcare stock, AMGN's price/sales ratio is 55.95% lower, now standing at 5.
  • Over the past 243 months, AMGN's price/earnings ratio has gone down 35.2.
  • Over the past 243 months, AMGN's price/sales ratio has gone down 13.1.

Below are key valuation metrics over time for AMGN.

Stock Date P/S P/B P/E EV/EBIT
AMGN 2021-08-31 5.0 15.5 22.3 20.1
AMGN 2021-08-30 5.0 15.4 22.1 20.0
AMGN 2021-08-27 5.0 15.3 22.0 19.9
AMGN 2021-08-26 4.9 15.2 21.9 19.8
AMGN 2021-08-25 4.9 15.3 21.9 19.8
AMGN 2021-08-24 5.0 15.4 22.2 20.0

AMGN Growth Metrics

  • Its year over year net cashflow from operations growth rate is now at 10.89%.
  • The 3 year price growth rate now stands at 10.79%.
  • Its 5 year revenue growth rate is now at 11.69%.
AMGN's revenue has moved up $2,165,000,000 over the prior 33 months.

The table below shows AMGN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 25,484 9,556 5,746
2021-03-31 25,164 10,467 7,085
2020-12-31 25,424 10,497 7,264
2020-09-30 24,987 10,858 7,352
2020-06-30 24,301 10,867 7,299
2020-03-31 23,966 9,439 7,675

AMGN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AMGN has a Quality Grade of A, ranking ahead of 97.98% of graded US stocks.
  • AMGN's asset turnover comes in at 0.408 -- ranking 112th of 677 Pharmaceutical Products stocks.
  • UTHR, VNDA, and AERI are the stocks whose asset turnover ratios are most correlated with AMGN.

The table below shows AMGN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.408 0.753 0.169
2021-03-31 0.395 0.756 0.196
2020-12-31 0.400 0.758 0.206
2020-09-30 0.398 0.767 0.220
2020-06-30 0.395 0.782 0.225
2020-03-31 0.399 0.799 0.231

AMGN Price Target

For more insight on analysts targets of AMGN, see our AMGN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $250.00 Average Broker Recommendation 1.76 (Moderate Buy)

AMGN Stock Price Chart Interactive Chart >

Price chart for AMGN

AMGN Price/Volume Stats

Current price $213.61 52-week high $276.69
Prev. close $215.05 52-week low $210.28
Day low $213.20 Volume 1,908,700
Day high $215.53 Avg. volume 2,599,539
50-day MA $228.50 Dividend yield 3.3%
200-day MA $237.83 Market Cap 121.30B

Amgen Inc. (AMGN) Company Bio


Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980. Amgen's Thousand Oaks staff in 2017 numbered 5,125 (7.5% of total city employment) and included hundreds of scientists, making Amgen the largest employer in Ventura County. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology. (Source:Wikipedia)  


AMGN Latest News Stream


Event/Time News Detail
Loading, please wait...

AMGN Latest Social Stream


Loading social stream, please wait...

View Full AMGN Social Stream

Latest AMGN News From Around the Web

Below are the latest news stories about Amgen Inc that investors may wish to consider to help them evaluate AMGN as an investment opportunity.

Global Systemic Lupus Erythematous SLE Drug Market is Expected To Grow With Impressive Growth Rate Between 2021 To 2027 | GSK, UCB, HGS, ImmuPharma, Amgen, Anthera Pharmaceuticals BMS

Recent market study "Systemic Lupus Erythematous SLE Drug Market" analyses the crucial factors of the Systemic Lupus Erythematous SLE Drug market 2021-2027 based on present industry situations, market demands, business strategies adopted by Systemic Lupus Erythematous SLE Drug market players

OpenPR | September 23, 2021

Thursdays Top Analyst Upgrades and Downgrades: Amgen, Biogen, Commscope, Lockheed Martin, ONEOK, Plug Power, Roku and More

No summary available.

24/7 Wall street | September 23, 2021

Amgen (AMGN) Presents At 5th Annual Best Ideas Growth Virtual Conference Big 5 - Slideshow

The following slide deck was published by Amgen Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | September 22, 2021

Massive Growth in Silent Cancer Therapeutics Market Set to Witness Huge Growth by 2027 | Abbott, Amgen, Bayer, Bristol-Myers Squibb

Cancers that are detected late in life are addressed by silent cancer therapies. Because many illnesses are asymptomatic, diagnosis is difficult until the condition has progressed to an advanced state. Ovarian cancer, pancreatic cancer, prostate cancer, esophageal cancer, liver cancer,

OpenPR | September 22, 2021

Psoriasis Drugs Market to Garner $27.65 Billion by 2027 | Key Players are Merck & Co., Abb Vie Inc., Amgen Inc., Eli Lilly & company, Sun Pharmaceutical Industries Ltd

Global Psoriasis Drugs Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027- Increasing number of psoriasis patients, rising number of psoriasis research and pipeline drugs and growing technological advancements are anticipated to drive the growth of Global Psoriasis Drugs

OpenPR | September 22, 2021

Read More 'AMGN' Stories Here

AMGN Price Returns

1-mo -3.55%
3-mo -11.30%
6-mo -14.98%
1-year -9.82%
3-year 12.59%
5-year 41.97%
YTD -5.02%
2020 -1.99%
2019 27.60%
2018 15.23%
2017 22.27%
2016 -7.56%

AMGN Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full AMGN Dividend History

Continue Researching AMGN

Want to see what other sources are saying about Amgen Inc's financials and stock price? Try the links below:

Amgen Inc (AMGN) Stock Price | Nasdaq
Amgen Inc (AMGN) Stock Quote, History and News - Yahoo Finance
Amgen Inc (AMGN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9322 seconds.